We investigated whether ACTN3, ENPP1, ESR1, PITX1, and PITX2 genes which contribute to sagittal and vertical malocclusions also contribute to facial asymmetries and temporomandibular disorders (TMD) before and after orthodontic and orthognathic surgery treatment. Methods: One hundred seventy-four patients with a dentofacial deformity were diagnosed as symmetric or subdivided into 4 asymmetric groups according to posteroanterior cephalometric measurements. TMD examination diagnosis and jaw pain and function (JPF) questionnaires assessed the presence and severity of TMD. Results: Fifty-two percent of the patients were symmetric, and 48% were asymmetric. The asymmetry classification demonstrated significant cephalometric differences between the symmetric and asymmetric groups, and across the 4 asymmetric subtypes: group 1, mandibular body asymmetry; group 2, ramus asymmetry; group 3, atypical asymmetry; and group 4, C-shaped asymmetry. ENPP1 SNP-rs6569759 was associated with group 1 (P 5 0.004), and rs858339 was associated with group 3 (P 5 0.002). ESR1 SNP-rs164321 was associated with group 4 (P 5 0.019). These results were confirmed by principal component analysis that showed 3 principal components explaining almost 80% of the variations in the studied groups. Principal components 1 and 2 were associated with ESR1 SNP-rs3020318 (P \0.05). Diagnoses of disc displacement with reduction, masticatory muscle myalgia, and arthralgia were highly prevalent in the asymmetry groups, and all had strong statistical associations with ENPP1 rs858339. The average JPF scores for asymmetric subjects before surgery (JPF, 7) were significantly higher than for symmetric subjects (JPF, 2). Patients in group 3 had the highest preoperative JPF scores, and groups 2 and 3 were most likely to be cured of TMD 1 year after treatment. Conclusions: Posteroanterior cephalometrics can classify asymmetry into distinct groups and identify the probability of TMD and genotype associations. Orthodontic and orthognathic treatments of facial asymmetry are effective at eliminating TMD in most patients. (Am J Orthod Dentofacial Orthop 2017;152:631-45) 
G enesis creating symmetry and breaking of symmetry are normal developmental biologic processes. In embryogenesis, symmetry is maintained until late gastrulation and early neurulation. The nodal pathway regulates signal transduction to maintain symmetric dorsal-ventral patterning of the mesoderm and the developing nervous system. 1 The lefty proteins, a subclass of transforming growth factor-b transcription proteins, act as extracellular antagonists to the nodal pathway. During gastrulation, lefty disrupts the symmetry in germ layers to pattern normal situs positioning of the heart, lungs, and gut coiling. 2 In the harmonious development of brachial arches immediately rostral, maintenance of symmetry is particularly important for natural midline fusion between the right and left sides. Many genetic and environmental factors, acting separately or in unison, may produce facial clefting or developmental jaw defects in arch development. 3 Due to the potential for congenital defects, different and more subtle influences on asymmetry might be active in normal facial development. PITX2, an upstream effector of nodal and lefty signaling pathways, has recently been identified as differentially expressed between the left and right masticatory muscles in adults with facial asymmetry. 4 PITX2 is necessary for mesoderm-derived first brachial arch structures, including masticatory muscles, jaw bones, and ectoderm induction for tooth formation. 5, 6 Therefore, it is likely that early developmental events persist into maturation, making asymmetry an etiologic and diagnostic challenge for clinical orthodontics. 7 Craniofacial asymmetry may be considered a type of dentofacial deformity that arises during facial maturation at the same time that sagittal and vertical jaw discrepancies become clinically evident. The association of skeletal asymmetry with Class II or Class III skeletal malocclusion varies with the population being treated, ranging from 8% to 50% and indicating that genetic influences from gastrulation to maturation play an important role in etiology. 8, 9 Skeletal malocclusions are complex trait conditions, developing from an interplay of genetic and functional (environmental) influences 10 ; new findings point toward a similar etiology for facial asymmetry. 11 To identify genetic contributions to skeletal malocclusions, a relatively precise description of phenotype and phenotypic variations is necessary. In orthodontics, there have been many approaches for classification of skeletal asymmetry using either posteroanterior cephalograms or submentovortex radiographs; however, there is no universally accepted method or classification system. Most recently, cone-beam computed tomographic (CBCT) imaging has been used to more accurately describe and subclassify the types of craniofacial asymmetry in populations with dentofacial deformity. 12, 13 The classification system of Baek et al 14 has identified 4 types of asymmetry with computed tomography that arise from different growth imbalances of the jaws, teeth, nasal septum, and cranial base. These new classification systems help remove much of the previous diagnostic uncertainty, since asymmetry can be masked by variations in head posture, canting of the occlusal plane, or other dental and soft tissue compensations. 14, 15 This etiologic-based phenotypic classification may be useful in identifying gene single nucleotide polymorphisms (SNPs) associated with asymmetry.
We have been investigating how genetic variations are associated with the development of skeletal malocclusions in patients undergoing orthognathic surgery at the University of Lille in France. This is a typical population of French patients, relatively young with a normal distribution of open-bite, deepbite, Class II, and Class III skeletal malocclusions. In our subjects and in other studies of patients with dentofacial deformity, pain in the temporomandibular joint or masticatory muscles is a common and often debilitating comorbid condition 16 estimated to occur in over 50% of these patients. 17 The classification of Baek et al 14 might also be useful in identifying an association between the subclasses of asymmetry and the prevalence of temporomandibular disorder (TMD).
In previous studies, we identified significant associations between SNPs in ACTN3 (a-actinin 3) and ESR1 (estrogen receptor a) with Class II malocclusion and ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) with mandibular prognathism. 10, 18 We also found differences in gene expression for PITX1 and PITX2 between the left and right masseter muscles in subjects with assymetrey. 4 In this study, we explored associations between these genes and subclassifications of asymmetry. We also sought to determine whether the subclassifications are related to the prevalence or severity of TMD before and after orthodontic treatment with jaw osteotomy.
MATERIAL AND METHODS
For this study, we recruited 174 patients undergoing comprehensive orthodontic treatment with mandibular or mandibular and maxillary osteotomies for correction of jaw deformities during their presurgical consultations at the Department of Oral and Maxillofacial Surgery at the University of Lille. At that time, the patients signed consent for participation according to human subject research protocols approved by the Committee for Personal Protection, University of Lille (CPP 12/44), and the institutional review board committees at the University of Pittsburgh (PRO 12080373) and Temple University (13438). The patients provided a saliva sample collected in Oragene kits (DNA Genotek, Ontario, Canada) for genotyping. Deidentified demographic information, panoramic radiogram, lateral and posterior anterior cephalograms, and clinical examination information were compiled for analysis. The subjects had a mean age of 25.7 years; the majority were female (76%), and there was a normal mixture of sagittal (66% Class II, 33% Class III) and vertical jaw deformations (75% with open bite, 25% with deepbite). Sagittal and vertical malocclusion classifications were based on the Delaire Cephalometric Analysis of lateral cephalograms, which is particularly useful in planning the type of osteotomy repositioning necessary to correct the malocclusion. 19 Skeletal asymmetry was classified into 4 groups based on a new system adapted from Baek et al 14 : group 1, lateralization of the mandibular body only (mandibular body asymmetry); group 2, difference in ramus heights with menton deviation to the shorter ramus side (ramus asymmetry); group 3, difference in ramus heights with menton deviation to the longer ramus side, gonion contour more prominent on the larger mandibular side, and reverse maxillary canting (atypical asymmetry); and group 4, difference in ramus heights with menton deviation to the short ramus side and severe maxillary canting (C-shaped asymmetry) (Fig 1) . Since this classification system was derived from CBCT images of orthognathic patients, we developed a posteroanterior cephalometric analysis, which allowed us to perform comparable measurements using digital 2-dimensional images with morphometric software (Dolphin Imaging, Chatsworth, Calif).
Six cephalometric measurements were used: occlusal plane tilt, maxillary canting, menton deviation, mandibular width to midsagittal plane, mandibular width to menton, and ramal height (Tables I and II) . In the maxilla, occlusal plane tilt was determined by the difference between the Frankfort horizontal and the horizontal line bisecting the buccal cusp tips of the maxillary and mandibular right first molars, as well as the buccal cusp tips of the maxillary and mandibular left first molars, measured in degrees. If the occlusal plane tilt was greater than 2 , the subject was considered to have maxillary canting. To further verify that the maxillary canting was skeletal in its etiology, the left and right vertical distances from the jugal process and the frontozygomatic suture were compared. If the difference between the left and right sides was greater than 3 mm, the subject was considered to have maxillary canting. In the mandible, menton deviation was determined by the angle between the midsagittal plane and the line connecting anterior nasal spine and menton. If the angle was greater than 2 , the subject was considered to have mandibular facial asymmetry with menton deviation. To compare the left and right mandibular widths, the distance between the antegonial notch and the midsagittal plane was compared with the contralateral side. If the difference was greater than 2 mm, the subject was considered to have mandibular deviation. We also measured the distance between the antegonial notch and menton, and compared it with its contralateral side. Again, if the difference was greater than 2 mm, the subject was considered to have mandibular body asymmetry. Ramal heights of the left and right sides were compared. If the difference between the 2 sides was greater than 3 mm, ramus asymmetry was diagnosed. Subjects were diagnosed as symmetric if there was no maxillary canting (\2 ), no menton deviation (\2 ), and no significant difference in ramal height (\3 mm). Asymmetric subjects were further divided into 4 groups. Group 1 subjects had a menton deviation greater than 2 without maxillary canting or a significant ramal height difference. Group 2 subjects had a menton deviation greater than 2 with a shorter ramal height on the deviated side. Group 3 subjects displayed atypical symmetry, with a shorter ramal height opposite the deviated side and slight maxillary canting toward or opposite the deviated side. Group 4 subjects showed both shorter ramal height and maxillary canting toward the deviated side, displaying C-shaped asymmetry as described by Baek et al. 14 Furthermore, principal component analysis explaining more than 5% of the facial skeletal variation was selected for genotype-phenotype correlation analysis. Data were normalized and standardized using a linear model to assess the possible effects of age and sex and to consider the possibility of age-by-sex interactions.
Saliva samples, 1 per patient, were collected in the Oragene kits and prepared for DNA extraction and posterior genotyping using TaqMan chemistry and end-point analysis in an automatic sequence-detection instrument (ABI Prism 7900HT; Applied Biosystems, Foster City, Calif), as described previously. 10 Thirteen SNPs were selected for genotyping: in ACTN3 rs1815739 and rs678397 10 ; in ENPP1, rs937300, rs6569759, rs858339, and rs1409181 18, [20] [21] [22] ; in ESR1, rs1643821, rs302318, rs3020377, and rs2077647 18, [23] [24] [25] [26] ; in PITX,1 rs1131611; and in PITX2, rs2595110 4 to determine whether specific allelic variants were overrepresented in subjects with malocclusion subclassifications. Thirty-three additional anonym SNPs were genotyped.
TMD was assessed using the routine clinical examination done by maxillofacial surgeons before surgical treatment and entered into the Research Diagnostic Criteria for Temporomandibular Disorders. 27 In addition, the jaw pain and function (JPF) questionnaire was used to determine the presence and severity of TMD, as a subjective patient report. This questionnaire was developed as a screening tool to determine the presence or absence of TMD conditions. 28 It consists of 8 questions relating to jaw pain and 5 questions related to jaw function. The questionnaire has been validated to reliably distinguish between normal and TMD subjects with up to 98% sensitivity and 100% specificity when a cutoff score of 6 is used for responses. 29 The questionnaire has been translated for use in German, 30 and we prepared a French version for our use as a standard assessment of the presence and severity of TMD. 18 One hundred twenty-one patients attended a 1-year posttreatment reevaluation appointment, where they completed a second JPF survey. Patients were divided into 5 groups for comparative purposes based on the difference in presurgical and 1-year posttreatment JPF scores. They were classified in the following 5 groups: no change in TMD, improvement of TMD if the JPF score decreased by 3 or more; worsening of TMD if the JPF score increased by 3 or more; cured of TMD if the JPF score was 6 or greater before surgery and less than 6 after treatment; and iatrogenic TMD if the JPF score was less than 6 before surgery and greater than 6 after treatment. We used the terms "cured" or "iatrogenic" since a score of 6 or greater is diagnostic for the presence or absence of TMD with the JPF assessment.
Statistical analysis
For the cephalometric assessment of asymmetry, an unpaired t test was used to compare whether differences between sides for individual cephalometric measurements were significantly different between the symmetric and asymmetric patients. Analysis of variance (ANOVA) was used between the 4 subclassifications of asymmetry to determine anatomic differences between them. Tests for measurement error included intrarater reliability in cephalometric measurements; repeating the cephalometric tracings on 10% of the radiographs by 1 examiner (K.C.) resulted in an R 2 value of 0.98.
For genotype assessment, the subjects' characteristics were analyzed with the usual rules of descriptive statistics: frequencies and percentages for categorical variables, and means and standard deviations for quantitative variables. The associations between the changes in JPF scores, TMD diagnoses, and the subjects' clinical or surgical characteristics were assessed with the chi-square test for categorical variables or the Fisher exact test in the case of small numbers. Quantitative variables were analyzed using the Student t test. When the distribution of the variable was not normal, the nonparametric Wilcoxon test was performed. After ensuring compliance with the HardyWeinberg equilibrium, the association of different SNPs was also sought with the chi-square or Fisher exact test when there were small numbers. For each SNP, the analysis was performed by considering the 3 genotypes separately, as well as by calculating the total number of alleles.
For principal component analysis, SNPs were coded 0, 1, and 2 according to the number of minor allele copies. Multivariate linear regressions adjusting for age, sex, and ethnicity were performed to test for associations between each SNP (1 at a time) and the selected principal components. The same Bonferroni threshold described above was used here. All analyses were performed with SPSS software for Windows (version 20.0; IBM, Armonk, NY).
For the TMD assessment, an unpaired t test was used to determine whether there were significant differences in presurgical JPF scores between symmetric and asymmetric patients, and ANOVA was performed between the 4 asymmetric groups. ANOVA was also used to compare any significant changes in JPF scores 1 year after treatment between the symmetric group and the 4 asymmetric groups. To further evaluate, a post hoc t test was done to compare individual JPF scores in the asymmetric groups.
RESULTS
The patient population represented a normal demographic distribution of subjects seeking orthodontic and orthognathic surgery treatment for dentofacial deformity malocclusion from the geographic areas of Northern France and Southern Belgium. All patients treated for this condition were referred to the Oral and Maxillofacial Surgery Department at the University of Lille under the National Health Care Service of France. Fifty-two percent of the patients were diagnosed as symmetric, and 48% were diagnosed as asymmetric. Segregating the asymmetric subjects into the 4 proposed subtypes was relatively easy to accomplish with the 11 cephalometric anatomic landmarks and 6 cephalometric measurements (Tables I and II ; Fig 1) . This classification system was validated by the significant differences obtained by comparing the cephalometric measurements between the symmetric and asymmetric groups, and the asymmetric subtypes (Table III) . All 6 posteroanterior cephalometric measurements were compared between the symmetric and asymmetric patients, and across the 4 asymmetry subclassification groups. For the bilateral points, the values are the difference between the left and right sides. The posteroanterior cephalometric analysis results demonstrated significant differences in all 6 cephalometric measurements between the symmetric and asymmetric patients. All mandibular measurementsmenton deviation, mandibular width, and ramal heightshowed notably significant differences between the symmetric and asymmetric patients, clearly indicating mandibular asymmetry.
Cephalometric measurements were also compared across the different asymmetry groups (Fig 2) . Generally, group 4 showed greater amounts of canting and deviation when we compared cephalometric measurements. The subjects in this group had the most severe malformations, with occlusal plane tilt, maxillary canting, and mandibular deviation that were proportionally much more imbalanced than in the other asymmetry groups. Because group 4 had maxillary canting, the anterior nasal spine to menton line used to measure chin deviation in the mandible was higher than in the other 3 groups (P 5 0.003; Fig 2) . The second characteristic evident with asymmetry was the worsening of the ramal height differences from group 1 to group 4. Differences in the posteroanterior cephalometric measurements indicated that the 4 subtypes may be considered as anatomically different forms of asymmetry that can be compared for differences in genotype variations. We therefore compared differences in genotype for the symmetric and asymmetric subjects and between the asymmetric subtypes (Table IV) .
Significant differences were detected for the ENPP1 and ESR1 genotypes, but not for ACTN3, PITX1, and PITX2. ENPP1 SNP rs6569759 was significantly different for genotype and alleles for group 1 compared with the other asymmetry subtypes. ENPP1 SNP rs858339 was different for genotype between the symmetric and asymmetric groups and for group 3 compared with the other asymmetric groups. ESR1 SNP rs1643821 was also significantly different for genotype and allele for group 4 compared with the other asymmetric groups. Subjects with group 1 asymmetry were almost 4 times more likely to carry the G allele of ENPP1 rs6569759 (odd ratio, 3.89; 95% confidence interval, 1.02-14.78). These results further support the appropriateness of the asymmetry subclassifications, since this phenotypic organization can be used to recognize meaningful genotypic differences.
Principal component analysis disclosed 3 principal components (PC1 to PC3) explaining more than 5% of the shape variations in the asymmetric subjects. The cumulative variation score of each component totaled 79.768% of the subjects' variability (Supplemental Table I ). PC1 comprised 39.721% of the sample variability and showed asymmetric subjects with low values for occlusal plane tilt angle and high values for maxillary canting. PC2 comprised 23.976%, with low scores for occlusal plane tilt and mandibular width to midsagittal plane, and high scores for menton deviation. PC3 showed 16.070% of shape variability and low scores for mandibular width to menton and high scores for ramal height. Regarding principal component analysis and the subjects' genotypes, PC1 and PC2 were associated with SNP in ESR1 (rs3020318) (P 5 0.04) (Supplemental Table II ). To determine how variations in principal components related to posteroanterior cephalometric measurements, we used the varimax rotation with the Kaiser normalization method to plot components in rotated space. Variance in total cephalometric measurements for each symmetric or asymmetric patient was visualized by a component plot rotated in space (Fig 3) . A second component plot visualized the variance in each cephalometric measurement for all patients (Fig 4) . Since these subjects often had TMD before treatment, we wanted to know whether there was a higher prevalence within and between asymmetry subclassifications. TMD diagnoses were positive in only 3% of the symmetric patients and high in the asymmetric patients (Table V) . Disc displacement with reduction was most common in the asymmetric patients (78%), followed by 61% with myalgia of masticatory muscles, 33% with arthralgia, and 12% with TMD-related headache. Disc displacement without reduction was the least common Axis I diagnosis at 6%. Overall, the population was young, with an average age of 26 years and without fibromyalgia or pain-related disability diagnosed in Axis II of the diagnostic criteria. When we compared genotypes with TMD diagnosis for disc displacement with reduction, myalgia, and arthralgia, and not disc displacement without reduction or TMDrelated headache, since these groups had few subjects, ENPP1 rs858339 had significant associations for genotype or allele for all 3 TMD diagnoses (Table VI) .
We used the JPF questionnaire as an efficient assessment tool for patient perceptions of the presence and severity of TMD. Most symmetric subjects had few or no symptoms of TMD and an average JPF score of 1.97, which agreed with the clinical examination assessment for TMD (Table VII) . Asymmetric subjects had an average JPF score of 6.87, which was significantly higher than in the symmetric patients. Furthermore, there were significant differences within the asymmetric subtypes, with group 3 having the highest average score of 9.11, and groups 1 and 4 having the lowest average scores of about 4. When we compared JPF scores between groups, a t test demonstrated significant differences between the symmetric and asymmetric patients (P \0.001). Among the asymmetric patients, an ANOVA comparison also showed significant differences between subclassifications. These results indicated a more likely chance for signs or symptoms of TMD when asymmetry is part of a patient's dentofacial deformity.
After treatment, we followed the subjects for 1 year to determine whether TMD improved or worsened, or new conditions occurred. Overall, those without TMD remained so, with 52% of the patients having no change in JPF score (Fig 5) . Twenty percent of all patients were cured of TMD, with posttreatment JPF scores below 6, and 17% had improvement with JPF scores decreased by 3 or more. Four percent of the patients had worsening of TMD after treatment, with JPF scores increased by 3 or more. Finally, 7% could be diagnosed with TMD with JPF scores less than 6 before surgery and greater than 6 after treatment. All groups, including the symmetric group, had decreases in posttreatment JPF scores that were statistically significant by ANOVA comparisons (P\0.001). Further post hoc t tests showed significantly greater decreases in posttreatment JPF scores for asymmetry groups 2 and 3 compared with the symmetric group (P \0.001). 
DISCUSSION
Craniofacial asymmetry, which arises from normal developmental processes, takes many shapes and forms, given the complexity of the nervous, skeletal, muscular, and physiologic components that drive cognitive, sensory, stomatognathic, and respiratory functions. 31, 32 A functional variation or genetic polymorphism influencing a subject or multiple components can lead to a localized skeletal asymmetry or a generalized craniofacial asymmetry depending on the cause and growth response over time. 33 Lateral skeletal distortions are known to occur in the skull 34 ; cranial base 35, 36 ; and midfacial structures, including the vomer, pterygoid process, piriform apertures, and maxilla 4 ; and in the mandible by hemimandibular elongation or hyperplasia. 37 These ubiquitous configurations of asymmetry have made simple classifications for patterns of craniofacial growth or etiology elusive. Yet a systematic classification system is needed to more accurately plan surgical corrections 14, 38 and serve as a phenotypic clustering for gene association studies. 39 Using either traditional tracings of posteroanterior cephalograms 9 or cluster analysis of 3-dimensional computed tomographic image analysis, a classification system with 4 groups or subtypes of craniofacial asymmetry has been formulated for Korean people.
14 Our first objective was to determine whether French people with asymmetry could also be subclassified using this diagnostic grouping. We adapted the asymmetry classification system of Baek et al, 14 which used 3-dimensional computed tomography, with a new cephalometric analysis of posteroanterior cephalograms for our patients. The diagnostic classification identified differences between groups because of the significant differences in cephalometric measurements. However, the French subjects differed from the Koreans in the percentages of distribution among the asymmetric groups. Koreans were more likely to have group 1 or group 2 asymmetry, whereas the French were more likely to have group 2 or 3 asymmetry. The French patients were almost equally matched; 52% of the subjects undergoing orthognathic surgery were symmetric, and 48% were asymmetric. To our knowledge, no similar estimates are available for Koreans, but in Singapore, the prevalence of asymmetry ranges from 8% to 50% in orthognathic surgery patients. 9 These population differences most likely stem from 3 distinct influences. The first is the tendency for the percentage of asymmetry to differ in different combinations of Class II, Class III, and open-bite and deepbite malocclusions. 8 The second is the almost certain likelihood that genetic differences in facial shape that mark race and ethnicity can also influence the distribution of asymmetry subclassifications. 4 Finally, there were differences in the type of images used in diagnosis and some differences in the morphology of asymmetry subclassification groups.
Although posteroanterior cephalometric analysis has been the traditional approach for diagnosis of asymmetry, variability of head positioning in the cephalostat may introduce radiographic projection errors that diminish diagnostic reliability. 40 CBCT images are considered more reliable for diagnosis of asymmetry, but there is insufficient evidence to conclude that CBCT is superior to posteroanterior cephalograms for detecting transverse facial differences. 41 We routinely use posteroanterior cephalograms in surgical treatment planning of patients and attempt to minimize head rotation around the vertical z-axis where most projection errors occur. 42 A second potential error is landmark identification due to unclear radiographic representations of anatomic locations. However, the 4 patterns of asymmetry are almost always discernible by visual observation, which helps decrease uncertainty as to where landmarks are located. There have been limited reports on landmark identification on posteroanterior cephalograms, 43 but a recent study (Ulkur et al 44 ) estimated rater reliability to be consistently high at 0.9 to 0.95, or above for most points. Our intrarater reliability had an R 2 value of 0.98 and was similar to that of Ulkur et al. Therefore, our methods may introduce some measurement error in diagnosis, but given the large differences in specific cephalometric measures between groups (Fig 2) , it was not a major influence on the classification of subjects into asymmetry groups.
The second study objective was to determine whether gene variations already identified as contributing to sagittal and vertical malocclusions (ACTN3, ENPP1, ESR1, PITX1, and PITX2) might also be associated with asymmetry (Table IV) . We compared 12 SNPs to determine differences for genotype and allele between symmetric and asymmetric patients and between the asymmetric groups. Two SNPs were associated with differences in both genotype and alleles when compared between asymmetry groups. SNP rs6569759 in ENPP1 was different in group 1, and SNP rs1643821 in ESR1 was significantly different in group 4. The SNP rs858339 in ENPP1 was significantly different for genotype between symmetric and asymmetric subjects and between asymmetric groups for group 3.
ENPP1 has pleotropic effects for mineralization and insulin signaling. The intronic SNP rs6569759 has previously been associated with an increased risk for type 2 diabetes, which results in insulin-mediated glucose metabolism that affects fiber type composition of skeletal muscles. 45 The SNP has also been associated with changes in bigonial width dimensions in western Eurasians. 46 This corroborates our finding that rs6560759 was significantly different in group 1, which has asymmetry in mandibular body breadth but not in ramus height. Rs858339 is an intronic SNP previously associated with variations in bone mineral density. 47 We recently reported that rs858339 has a significant association with preoperative TMD in our patients.
18
ENPP1 rs858339 TT genotype was associated with pretreatment absence of TMD and the AT genotype as a pretreatment risk factor for TMD as determined by JPF scores. 18 In this study, rs858399 had strong statistical associations with the TMD diagnoses of disc displacement with reduction, masticatory muscle myalgia, and arthralgia, further confirming its role in etiology (Table V) . The association of ENPP1 with TMD diagnoses or asymmetry group 3 is not yet informative as to the biologic mechanisms responsible. The conditions of arthralgia and disc displacement may be related to ENPP1 biomineralization functions and myalgia to insulin signaling in skeletal muscles, but more investigations are necessary to confirm these possibilities.
ESR1 polymorphisms are associated with skeletal Class II malocclusions and symptomatic osteoarthritis of the temporomandibular joint in Korean women. 48 The rs1643821 intron SNP contributes to the susceptibility for osteoporotic fracture in postmenopausal Chinese women. 49 Since the incidence of TMD in group 4 was relatively low, rs1643821 may be contributing to the development of this type of asymmetry through variations in bone mineral density with growth, rather than by specific problems in the temporomandibular joint.
We used principal component analysis as a secondary procedure for analysis of posteroanterior cephalometric measurements. Three components explained 80% of the morphologic variations found from cephalometric analysis. PC1 identified variability related to occlusal plane tilt and maxillary canting, PC2 to mandibular width and menton deviation, and PC3 to ramal height (Supplemental Table I ). A component plot rotated in space demonstrated clustering of symmetric patients for overall variance in cephalometric measurements that was separate from asymmetric patients (Fig 3) . Asymmetric patients also had greater variability in morphologic variations. A second component plot (Fig 4) summarized how the variation in individual cephalometric measurements identified in Figure 2 related to each other morphologically. Left and right ramal height and left and right maxillary canting clustered together, indicating that variations in these measures were similar between the left and right faces. Two opposite measures also clustered together: AG-menton with GAmidsagittal plane (MSR) and GA-menton with AG-MSR; indicating that menton deviation on 1 side of the face matched the variance in the mandibular body width on the opposite side. Variation in occlusal plane tilt was an independent morphologic entity with a limited relationship to other component variations. The relationship of ANS-Me-MSR was a second independent morphologic entity, which reflected the independent variation of nasal septal deviation relative to other facial structures.
Genotype analysis was associated with SNP rs3020318 in ESR1 with PC1 and PC2 (Supplemental Table II ).
Although not directly comparable with the genotype associations for the 4 asymmetry groups, the principal component analysis provided a confirmatory finding. ESR1 rs1643821 was associated with asymmetry group 4 and rs3020318 with PC1 and PC2, which relate to transverse canting and menton deviation, respectively; both of these morphologic features were found in group 4. Rs3020318 is an intronic SNP without any known functional effects. However, this marker belongs to a haplotype associated with a greater cancer risk. 50 There is growing evidence that the impact of genetic risk factors on breast cancer varies by hormone receptor status. Genetic variations of the estrogen metabolism pathway-particularly the genes involved in the production of estrogen through androgen conversion-influence the risk for the development of estrogen-sensitive breast cancer. 51 This could also be true for craniofacial deformities that include symptomatology in the temporomandibular joint, with variations in hormonal levels (ie, estrogen) influencing the risk for development of TMD.
Although there is no specific polymorphism associated with PITX2 and facial asymmetry, differences in gene expression were previously identified in right and left masseter muscle samples from asymmetric patients. 4 The variation in PITX2 gene expression most likely has an association with facial asymmetry and warrants further research. One possibility to be investigated is that PITX2 may interact with ENPP1 to produce differences in mineral density and bone growth between facial sides.
There is a broad consensus among orthodontists that little or no relationship exists between specific types of malocclusions and the development of TMD. 52 Yet for many people with jaw deformations, pain in the TMJ or the masticatory muscles is a common and debilitating comorbid condition estimated to occur in over 50% of patients with facial asymmetry. 16, 17 Our results affirm this finding. The JPF scores for asymmetric subjects were significantly higher than for symmetric subjects (P .0.0001). Furthermore, asymmetry groups 2 and 3 were most likely to have preoperative TMD before orthodontic treatment. To determine whether the musculoskeletal imbalances were the root cause of TMD, we followed these patients for at least 1 year after orthodontic treatment to see whether the condition resolved or persisted. Groups 2 and 3 were most likely to be cured of TMD at the 1-year follow-up, or at least they had significant symptom improvement (Fig 5) . There is growing evidence, confirmed in different populations, that patients with dentofacial deformities have a higher prevalence of TMD 53 ; when treated with combined orthodontic and surgical procedures, they usually have better masticatory function and improved TMD symptoms, especially for the relief of pain. 54, 55 These findings led to the conclusion that orthodontic and orthognathic treatment of craniofacial asymmetry helps to cure or alleviate TMD for most patients. However, as with any clinical treatment, a small percentage of patients had significant worsening or presentation of TMD symptoms in the retention phase (7%). Most of these (80%) were subjects without asymmetry, in whom we would not have expected this to occur. Other posttreatment conditions, such as condylar remodeling and condylar resorption, could influence this rare TMD occurrence and will be studied in the future. Because of the small number of subjects with this result, a total of 5, many more patients must be followed for further characterization of posttreatment development of TMD. Overall, these treatments are highly effective at correcting skeletal malocclusions, producing a physiologic balance that alleviates TMD symptoms.
CONCLUSIONS

1.
A new posteroanterior cephalometric analysis using 6 measurements to detect differences in facial sides has been developed to distinguish 4 main classifications of asymmetry that are common in patients with dentofacial deformity. 2. TMD prevalence is much higher in patients with asymmetry compared with patients with dentofacial deformity without asymmetry. The most common TMD presentations were disc displacement with reduction, masticatory muscle myalgia, and arthralgia. Two of the 4 asymmetry groups had both high positive diagnoses for TMD and subjective patient reporting of symptom. 3. SNP genotype rs6569759 in ENPP1 was associated with asymmetry group 1, and rs858339 was associated with asymmetry group 3. 4. SNP genotype rs1643821 in ESR1 was associated with asymmetry group 4. rs3020318 in ESR1 was associated with PC1 and PC2, which relate to maxillary canting and menton deviation. 5. SNP genotype rs858339 in ENPP1 was associated with disc displacement with reduction, masticatory muscle myalgia, and arthralgia. 6. Orthodontic and orthognathic treatment of asymmetry alleviates TMD symptoms for at least 1 year into retention in most patients.
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